在支持性和息性瘤学中进行临床试验:挑战和机遇
David Hui1,2,3, Eduardo Bruera1
1Department of Palliative, Rehabilitation and Integrative Medicine.
Current opinion in oncology
|February 18, 2026
概括
进行癌症支持性护理的临床试验面临诸如有限的资金和患者招募等挑战. 通过合作和创新设计克服这些障碍,将改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 支持性护理研究 支持性护理研究
背景情况:
- 高质量的研究对于改善癌症患者的支持性护理提供和结果至关重要.
- 在瘤学中的支持性护理临床试验面临着重大的结构和过程相关障碍.
研究的目的:
- 审查在瘤学中进行支持性护理临床试验的关键挑战.
- 讨论克服这些研究障碍的潜在解决方案和战略.
主要方法:
- 关于支持性护理研究中的挑战和解决方案的文献综述.
- 分析临床试验进行中的结构和过程障碍.
- 识别支持性护理研究中的新兴策略和趋势.
主要成果:
- 结构性障碍包括有限的基础设施,资金,基础研究和标准化术语.
- 过程障碍包括患者招募/保留,干预设计,对照选择和结果评估.
- 越来越多的意识,增加的研究活动,资金和出版物被注意到,以及创新的研究设计和多中心网络.
结论:
- 跨学科合作对于加强基础设施和完善支持性护理试验过程至关重要.
- 解决已识别的障碍将建立一个强大的证据基础.
- 这些努力的目的是最终改善癌症患者的治疗结果.
更多相关视频
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
15.3K
07:31Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
Published on: May 26, 2023
6.1K
相关概念视频
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Preclinical Development: Overview
6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
